These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 2252337)
61. 5-HT in nervous system disease and migraine. Fozard JR; Kalkman HO Curr Opin Neurol Neurosurg; 1992 Aug; 5(4):496-502. PubMed ID: 1515690 [TBL] [Abstract][Full Text] [Related]
62. [Sumatriptan and its use in treatment of migraine and cluster headaches]. Prusiński A Neurol Neurochir Pol; 1992; Suppl 2():28-48. PubMed ID: 1337766 [TBL] [Abstract][Full Text] [Related]
69. Evidence for 5-HT1B/1D receptors mediating the antimigraine effect of sumatriptan and dihydroergotamine. Buzzi MG; Moskowitz MA Cephalalgia; 1991 Sep; 11(4):165-8. PubMed ID: 1660351 [TBL] [Abstract][Full Text] [Related]
70. Vascular 5-HT1-like receptors that mediate contraction of the dog isolated saphenous vein and carotid arterial vasoconstriction in anaesthetized dogs are not of the 5-HT1A or 5-HT1D subtype. Perren MJ; Feniuk W; Humphrey PP Br J Pharmacol; 1991 Jan; 102(1):191-7. PubMed ID: 1675143 [TBL] [Abstract][Full Text] [Related]
71. Mechanisms of action of serotonin 5-HT1B/D agonists: insights into migraine pathophysiology using rizatriptan. Goadsby PJ; Hargreaves RJ Neurology; 2000; 55(9 Suppl 2):S8-14. PubMed ID: 11089513 [TBL] [Abstract][Full Text] [Related]
72. 5-Hydroxytryptamine (5-HT) and the initiation of migraine: new perspectives. Fozard JR; Kalkman HO Naunyn Schmiedebergs Arch Pharmacol; 1994 Sep; 350(3):225-9. PubMed ID: 7824037 [TBL] [Abstract][Full Text] [Related]
73. The relevance of preclinical research models for the development of antimigraine drugs: focus on 5-HT(1B/1D) and CGRP receptors. Gupta S; Villalón CM Pharmacol Ther; 2010 Oct; 128(1):170-90. PubMed ID: 20655327 [TBL] [Abstract][Full Text] [Related]
74. Neuroendocrine effects of subcutaneous sumatriptan in patients with migraine. Rainero I; Valfrè W; Savi L; Gentile S; Pinessi L; Gianotti L; Arvat E; Ghigo E; Del Rizzo P; Calvelli P; Limone P J Endocrinol Invest; 2001 May; 24(5):310-4. PubMed ID: 11407649 [TBL] [Abstract][Full Text] [Related]
76. Hypothesis: serotonin-1C receptor activation in migraine: an alternative point of view with therapeutic implication. Spierings EL Headache; 1991 Sep; 31(8):546-9. PubMed ID: 1960061 [TBL] [Abstract][Full Text] [Related]
77. Mechanisms and functions of serotonin neuronal systems: opportunities for neuropeptide interactions. Fuller RW Ann N Y Acad Sci; 1996 Mar; 780():176-84. PubMed ID: 8602731 [No Abstract] [Full Text] [Related]
78. Serotonin and its role in headache pathogenesis and treatment. Marcus DA Clin J Pain; 1993 Sep; 9(3):159-67. PubMed ID: 8219515 [TBL] [Abstract][Full Text] [Related]